With One Nucleus Corporate Sponsor Amgen acting as host, 5th June saw the largest and most diverse One Nucleus BIO Executive Dinner yet. The presentation sets out the what, why and who along with background information on One Nucleus and the London-Cambridge Life Science Cluster
3. About This Event
•5th
One Nucleus BIO Executive Dinner
•Originated from our aim to engage One Nucleus members
with members of our peer groups elsewhere
•45 attendees in 2012, 160 attendees in 2016
•2012 – Participation from UK, Massachusetts, California and
Medicon Valley Alliance present
•2016 - 12 countries and 7 US States present
8. Dr Susan
Windham-
Bannister
Biomedical
Growth
Strategies
Prof David
Roblin
The Francis
Crick
Institute
Prof Nick
Lemoine
NIHR and
Barts Cancer
Institute
Prof Sir
John
Savill
MRC
Dr Jane
Osbourn
MedImmune
Main sessions for ON Helix:
The Future of Medicines: Do patients make the best models?
Licensing your ideas: The Role of Technology Transfer Offices
‘I don’t know what all the fuss is about – funding for translational research is
fantastic in the UK and we don't really need more’ Agree or disagree?
www.onhelix.com
9. “The Science, Technologies and Business of
21st
Century Biomedical Innovation”
Lisa Urquhart Mene Pangalos Corinne Savill Yvonne Naughton Jennifer Laird
EP Vantage AstraZeneca Novartis Sanofi Eli Lilly
Key Tracks on:
-Advances in Pharmaceutical R&D Technologies
-Digital Health
-Latest Investment and Deal Trends and
“Winners & Losers 2016”
-Nurturing Innovation
Plenary Panel: “Demographics aside, what will drive Pharma Growth in C21st?”
11. What is One Nucleus?
A membership organisation
• Funded by sponsorship, membership
fees, events and projects
• Based in Cambridge and London but
with global members
• Formed by merger of ERBI and LBN
With more than 470 members
• Biotech, pharma, medical device,
diagnostics
• Technical and commercial service
providers
• 30% Gold, 70% Silver
The wider network provides
comprehensive coverage
Vision
For One Nucleus and our members to be the
top European life science and healthcare
network
Vision
For One Nucleus and our members to be the
top European life science and healthcare
network
Mission
To maximise the global competitiveness of
our members
Mission
To maximise the global competitiveness of
our members
Focused on member competitiveness, learning and
collaboration
12. • Est 500 SME biotech/medtech/digital health companies
• Major pharmaceutical companies
• 150 medical device companies (including supply chain)
• 140 healthcare trusts and leading hospitals for clinical trials
• Imperial NHS Trust, UCL Partners, King’s Health Partners,
Cambridge Healthcare Partners and the BioMedical Campus
Over 30 research institutions in life sciences:
• Universities; UCL, Imperial, Cambridge, Queen Mary UoL,
King’s College, Bloomsbury specialist colleges and more
• Wellcome Trust Sanger Centre, EBI/EMBL
• Francis Crick Insititute
• MRC Cancer Cell Unit (and 12 other MRC research centres)
• John Innes Centre, Institute of Food Research, Babraham
Institute, Rothamsted Research
The most successful life science cluster outside the USA
The Cambridge –
London Life Sciences Sector
15. • Regular member meetings
– Network Meetings Cambridge
– BioWednesdays London
• ON Helix Conference in Cambridge – 28 June 2016
• Life Science Leadership Seminars
• Genesis Conference in London – 1December 2016
• ON Insights – e-comms
• Social media - @OneNucleus, LinkedIn
Engaging with the One Nucleus,
Our Members & Network
16. • United Life Science
− BIA, One Nucleus, Biopartner.co.uk, Bionow, MediWales
− >1100 members, single route in, advocacy
• Public Support
− UK Trade & Investment, MedCity
• Peer Associations
− Academic, membership, commercial partnerships
• Our Members
− Seminars, webinars, e-comms
UK Collaborations
17. • Formal MOU Relations:
– MassBIO, MassMedic, BioNJ,
Pennsylvania Bio, Life Sciences
BC and BIOCOM
– Practical support for members
engaging with overseas clusters
and companies
• EU Relations: CEBR and 1-2-1
- EasySpeak
- Strong links to similar clusters
and events eg: BIO
International
18. • Courses based on identified skills gaps:
– Introduction to drug development
– Introduction to management
– Commercial awareness
– Presentation skills for scientists
– Project management
– Laboratory health and safety
– Health and safety for representatives and managers
– Directing safety (IOSH accredited)
• Rates for members and non-members
• Courses also in London and Manchester
• Courses are CPD accredited
Training
19. • Small groups to discuss key business issues
– Human resources
– Project management
– Corporate governance
– Business development
– IP
– IT
– Regulatory affairs/clinical development
– Corporate communications
– Operations (combining security, health and safety,
Purchasing)
– Training
Special Interest Groups
20. • Preferred Supply Agreements (tendered, exclusive) – now includes
BioNow members:
– Stationery & IT consumables
– Pipette maintenance & calibration
– Bulk gases, cylinder gases and dry Ice
– Laboratory consumables and chemicals
– Life science products
– Laboratory equipment maintenance
• Support Supply Agreements (not tendered or exclusive)
– Courier services, stationery, hotels, insurance, travel, cleaning
• £3 million annual savings
• Example 1
– £20,000 saving on top 40 most used lab consumables
– “The cost saving alone makes it worth joining”
• Example 2
– £49,559 saving (42%) against Fisher Scientific list prices vs £2,000 annual
membership cost
• Example 3
– £8,000 pa cost saving (12%) on equipment maintenance plus improved service
levels and payment terms
• Example 4
– £1,371 rebate under office supplies contract
• Example 5
– £3,267 saving by switching annual dry ice spend
Purchasing Scheme